Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.2M Buy
60,840
+300
+0.5% +$94.5K 1.18% 23
2026
Q1
$19.9M Buy
60,540
+60,240
+20,080% +$21.6M 1.37% 24
2025
Q4
$105K Sell
300
-7
-2% -$2.55K 0.01% 197
2025
Q3
$113K Buy
307
+207
+207% +$80K 0.01% 217
2025
Q2
$39.6K Hold
100
﹤0.01% 277
2025
Q1
$37.2K Hold
100
﹤0.01% 281
2024
Q4
$36K Hold
100
﹤0.01% 251
2024
Q3
$36.1K Hold
100
﹤0.01% 237
2024
Q2
$34K Hold
100
﹤0.01% 237
2024
Q1
$35.8K Hold
100
﹤0.01% 240
2023
Q4
$29.9K Hold
100
﹤0.01% 239
2023
Q3
$27.3K Hold
100
﹤0.01% 214
2023
Q2
$30.5K Sell
100
-50
-33% -$14.4K ﹤0.01% 229
2023
Q1
$42.8K Buy
+150
New +$39.8K ﹤0.01% 210

Other funds holding SYK

Avalon Trust's SYK Position: Q2 2026 in Review

Avalon Trust increased its Stryker (SYK) stake by 0.5% in Q2 2026, buying an estimated $94.5K and bringing the position to 60,840 shares worth $19.2M. The position accounts for 1.18% of the portfolio, ranked #23.

Avalon Trust first reported a position in SYK in Q1 2023 and has held it in 14 quarters since. The position peaked at $19.9M in Q1 2026. 2,259 funds tracked by Wall St. Rank hold SYK as of Q2 2026.

  • Avalon Trust held 60,840 shares of Stryker worth $19.2M as of Q2 2026.
  • Avalon Trust bought 300 Stryker shares in Q2 2026, an estimated $94.5K.
  • Stryker made up 1.18% of Avalon Trust's portfolio in Q2 2026, its #23 holding.
  • Avalon Trust first reported a position in Stryker in Q1 2023 and has held it in 14 quarters since.
  • Avalon Trust's Stryker position peaked at $19.9M in Q1 2026.
  • 2,259 funds tracked by Wall St. Rank held Stryker as of Q2 2026.

Based on Avalon Trust's 13F filing for Q2 2026, filed 6 Aug 2026.